Dear Colleague, Please find a link to the updated publication, “Guidance for the Content of SACT Protocol,” available here: https://www.uksactboard.org/publications. This document has been developed to support…
BOPA is an Ex-Officio Member (Specialist Pharmacy Group) of the UKPPL Board with our Chair, Joseph Williams, representing BOPA members and all Cancer Pharmacy Professionals. Through the Board’s work, closer…
We are pleased to announce that BOPA Fellowship Nominations have now opened for 2025. There is a clear nomination and selection process including specific criteria for assessing the nominated individuals.…
The 28th British Oncology Pharmacy Association (BOPA) Annual Conference, 3-5 October 2025, ICC Belfast The Draft Agenda is available to view here: https://www.bopa.org.uk/resources/the-28th-bopa-annual-conference-2025-draft-agenda/ The conference will include an exciting variety…
Dear Members, The BOPA research committee would like to invite members to participate in a research project on Genetic core competencies for clinical pharmacists in the cancer setting: a literature…
Overview – This study day is intended to provide an overview of the knowledge, skills, experiences and behaviours required to practice at an advanced level in Cancer Care. The study day…
Vacancy: BOPA Let’s Communicate Cancer Lead Closing Date: 8/6/25 Are you a passionate pharmacy professional with a strong interest in education and training? Do you have the experience and leadership…
Dear BOPA members, The Education and Training subcommittee are pleased to announce that our new e-learning module for myeloma is now live on the BOPA website. The module can…
Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…
Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…
The Spring webinar for Women for Oncology UK is on the 16th May, to sign up click the link below. Women For Oncology UK Spring Webinar Tickets, Wed 14 May…
BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…
